Key facts
- This page summarizes Paul A. Laviolette's Form 4 filing for ASENSUS SURGICAL, INC..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Jul 2021, 19:08.
Paul A. Laviolette - 30 Jun 2021 Form 4 Insider Report for ASENSUS SURGICAL, INC.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 30 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 19:08:46 UTC
- Prior SEC filing
- 07 May 2021
- Next SEC filing
- 08 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Weingard, as attorney-in-fact for Paul A. LaViolette
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Paul A. Laviolette filed Form 4 for ASENSUS SURGICAL, INC. on 02 Jul 2021.
Change
- Previous filing in this sequence was filed on 07 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASXC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +13,846
- Change %
- Price
- $0.000000
- Shares after
- 13,846
- Date
- 01 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASXC
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +10,025
- Change %
- Price
- $0.000000
- Shares after
- 10,025
- Date
- 30 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,025
- Exercise price
- $3.17
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Registrant's common stock.
Footnote F2
Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, provided that if the date of the 2022 annual meeting of stockholders is earlier, the restrictions will lapse on the date of the annual meeting.
Footnote F3
The Reporting Person has assigned shares issued from prior grants of restricted stock units to SV Health Investors in accordance with its operating agreement and is expected to transfer the shares underlying this reported award upon vesting.
Footnote F4
Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended June 30, 2021.
Footnote F5
The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors.